Fosamax Attorney Explains Dangers Of Fosamax
Dan Thornburgh, a Florida attorney whose practice focuses in pharmaceutical and medical device litigation, recently sat down with us to explain what Fosamax is - and why it's so dangerous.
Fosamax Lawsuits Allege That Merck Knew Of Risks, Failed To Warn Consumers
Fosamax, also known as a bisphosphonate, which is used to treat chemotherapy for metastatic cancers and non-cancerous conditions such as Osteoporosis, has been linked to Osteonecrosis of the Jaw (ONJ) - a debilitating process that is extremely painful. Lawsuits filed against Merck, the maker of Fosamax, allege the company knew of the risks, but failed to warn consumers.
Fosamax Lawyer Provides Answers To FAQs
Dan Thornburgh, a Florida attorney whose practice focuses in pharmaceutical and medical device litigation, recently sat down with us to provide answers to questions he gets asked most frequently about Fosamax.
Fosamax Lawsuits: Damages, Experts & Hiring An Attorney
As pharmaceutical giant Merck & Company defends numerous lawsuits from patients who have been injured by Fosamax, we asked an experienced drug litigation attorney to provide us with the lowdown on what damages are available, what types of experts are used in these types of cases and when someone should contact an attorney for help.
Fosamax Makers Of Creating Fake Medical Journals
Pharmaceutical giant, Merck & Company, has been accused of creating “fake” medical journals touting the benefits of its osteoporosis drug Fosamax. The global drug manufacturer has already been accused of deceptive marketing practices and is certainly creating the impression that it will do whatever it takes to boost sales. Unfortunately, it's consumer users who suffer the most.
First Case Over Osteoporosis Drug Fosamax & Jawbone Tissue Death Goes To Trial
The first lawsuit over injuries stemming from Merck's biophosphonate osteoporosis drug, Fosamax, and its link to osteonecrosis of the jaw, or ONJ, has begun in New York. Product liability lawyers say that between 1,000 and 2,000 lawsuits have been filed against the pharmaceutical giant alleging that the manufacturer misrepresented the drug's safety and failed to warn doctors and patients about the possibility of jawbone tissue death.